An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient

Immunotherapy with immune checkpoint inhibitors (ICI) is a new option of treatment in a growing range of neoplasms. In addition to an antitumor effect, ICI are associated with autoimmune reactions resulting in a wide spectrum of toxicities that have not been seen in patients receiving chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Krukowska, Kinga, Kieszko, Robert, Kurek, Katarzyna, Chmielewska, Izabela, Krawczyk, Paweł, Milanowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232686/
https://www.ncbi.nlm.nih.gov/pubmed/32455036
http://dx.doi.org/10.1155/2020/4196178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232686/
https://www.ncbi.nlm.nih.gov/pubmed/32455036
http://dx.doi.org/10.1155/2020/4196178

Ejemplares similares